Rhodiola Rosea and Exercise: What the Research Shows

Rhodiola rosea (also called golden root, arctic root, or roseroot) has been part of traditional medicine in Russia, Scandinavia, and Siberia for centuries, mostly for fatigue and stress. In the last two decades it has been pulled into the sports-supplement literature as a candidate ergogenic aid, with a small but growing base of randomized controlled trials in cyclists, resistance-trained athletes, and recreationally active adults.

The interesting thing about rhodiola is that it doesn't fit the classic ergogenic template. It isn't a stimulant like caffeine, it isn't a substrate like creatine, and it isn't a buffer like beta-alanine. It's classified as an adaptogen, a category defined more by its clinical fingerprint (reducing the stress response, improving perceived recovery, buffering fatigue) than by a single mechanism. That vagueness has drawn skeptics, and fairly so.

This article walks through the five most useful trials and reviews on rhodiola and exercise, from De Bock's foundational 2004 acute-dosing study to the 2023 systematic review and 2025 meta-analysis. What the research measured, what it found, and where rhodiola honestly earns a place in an evidence-based supplement stack (and where it does not).

The Research: What Studies Show

De Bock 2004: The Foundational Acute-vs-Chronic Cycling Trial

The rhodiola-and-exercise literature has one foundational study, and everything since has been in conversation with it. De Bock, Eijnde, Ramaekers, and Hespel (2004) at the Katholieke Universiteit Leuven ran a double-blind, randomized, crossover trial in the International Journal of Sport Nutrition and Exercise Metabolism with 24 recreational athletes. Two independent questions were asked in the same design. Does an acute pre-exercise 200 mg dose of rhodiola extract change endurance performance? And does 4 weeks of daily 200 mg supplementation add anything on top?

The answers landed cleanly on opposite sides. The acute dose produced a significant increase in time-to-exhaustion during an incremental cycle-ergometer test to volitional exhaustion. Ratings of perceived exertion at matched workloads were significantly lower in the rhodiola condition, and the effect emerged within the first 60 minutes of ingestion. The 4-week chronic supplementation phase, by contrast, produced no further significant improvement in the same endurance test. Neither did chronic dosing improve VO2max, blood lactate response, or blood glucose kinetics.

The extract used was standardized to 3 percent rosavins and 1 percent salidroside (the SHR-5 formulation), which became the reference standard for most subsequent exercise trials. This is the first study to show an acute impact of rhodiola on exercise performance in humans, and it set the acute-dosing template that every trial since has used as its comparison point.

Duncan and Clarke 2014: Rhodiola Cut Perceived Exertion at 70% VO2max

A decade later, Duncan and Clarke (2014) at Coventry University published in the Journal of Sports Medicine a double-blind, placebo-controlled crossover trial that zoomed in on the perceived-exertion angle. Ten physically active men (mean age 26) completed two 30-minute cycling trials at a steady 70 percent of maximum oxygen uptake, one hour after ingesting either 3 mg per kg of body mass of rhodiola extract or a placebo.

Heart rate did not differ between conditions, and neither did total energy expenditure or substrate utilization (fat versus carbohydrate oxidation). What did differ were the psychological outcomes. Ratings of perceived exertion were significantly lower during the rhodiola trial. Feelings of arousal and pleasure (as measured on the Feeling Scale and Felt Arousal Scale) were significantly higher. In other words, the exact same physiological work felt easier and more pleasant.

This is the mechanistic wedge that separates rhodiola from most sport-nutrition supplements. Caffeine also reduces RPE, but through central-nervous-system stimulation. Rhodiola appears to work through something closer to a mood-and-stress-buffering pathway, more like an anxiolytic than a stimulant. For the person who reliably drops out of hard workouts because they feel awful, that mechanism matters.

Ballmann 2019: 3 Days of Loading Boosted Anaerobic Wingate Power

The anaerobic side of the ledger had to wait until 2018 for a well-designed trial. Ballmann, Maze, Wells, Marshall, and Rogers (2019) at Samford University published in the Journal of Sports Sciences a double-blind, placebo-controlled crossover study in 11 physically active female college students. The dosing protocol was heavier than the earlier trials. Participants supplemented with 1500 mg of rhodiola (Golden Root Extract) per day for 3 days, then took an additional 500 mg 30 minutes before an all-out test.

The test was a 3 by 15 second Wingate anaerobic protocol on a cycle ergometer, with 2 minutes of active recovery between bouts. This is a brutal all-out format that hits the phosphocreatine system hard on bout 1 and forces the glycolytic and buffering systems to carry the load on bouts 2 and 3. Statistically significant differences favored rhodiola for mean power output, mean peak power, mean anaerobic capacity, mean anaerobic power, and total work. That is a clean sweep across the primary anaerobic metrics.

Two caveats. The sample was small (11), and it was female-only. The generalizability to male athletes and to different sports has not been fully tested. Still, the direction of the effect is consistent with the endurance literature. Rhodiola nudges the ceiling on hard work up, at least a little.

Sanz-Barrio 2023: The Systematic Review of 13 Sports-Performance RCTs

By 2023 the literature had grown enough to review systematically. Sanz-Barrio, Noreen, Schwarz, Lozano-Ramos, and Rodríguez-Rosell (2023) in Phytotherapy Research screened databases through March 2023 and included 13 randomized controlled trials involving 263 participants. The review examined effects on muscle damage biomarkers (creatine kinase, lactate, cortisol) and physical performance outcomes (endurance time, power output, strength).

The overall conclusion was that rhodiola supplementation shows modest but relatively consistent benefits on rating of perceived exertion and endurance-related outcomes, with more heterogeneous effects on maximal power and muscle-damage markers. The authors were careful to flag the small sample sizes typical of the individual trials, the variety of extracts and dosing schedules used, and the risk of publication bias (which is nontrivial in the supplement literature). But the direction of effect across the pooled trials was consistent enough to argue that the perceived-exertion signal is real.

This is the honest state of play. Rhodiola is not a case of "trials keep failing and marketers keep selling." The trials, on the whole, keep showing small positive effects. What they don't show is a magic-bullet result of the kind that a caffeine or creatine meta-analysis produces.

2025 Meta-Analysis: 26 RCTs in 668 Participants on Endurance Outcomes

The most recent synthesis, a 2025 systematic review and meta-analysis (Wang et al., 2025) in the Frontiers in Nutrition family of journals, pooled 26 randomized controlled trials totaling 668 healthy participants (mean age 22 years). The primary analysis was on endurance performance and related biomarkers including VO2max, time-to-exhaustion, oxidative stress markers, muscle-damage indices, inflammation, and metabolic markers.

The pooled effect on VO2max and time-to-exhaustion was significant and positive. The pooled effects on oxidative stress and inflammation markers were more variable, with some biomarkers moving in the expected direction and others not reaching significance. The muscle-damage picture was mixed. The heterogeneity across trials remained high, driven by differences in extract standardization, dosing protocol, participant training status, and outcome-measurement method.

The takeaway from the pooled 26-trial dataset is roughly the takeaway from the individual foundational trials. Endurance and perceived-effort outcomes shift in the expected direction. Biomarker outcomes tell a fuzzier story. The pooled effect size on the primary outcomes is small to moderate, and it is real.

Why This Matters for Your Fitness

For most FitCraft users training three to five times a week at home, the practical question is whether rhodiola belongs in a supplement stack. The honest answer is: only if you have a specific problem it addresses, and only after the higher-return moves are already in place.

The higher-return moves are the boring ones. Adequate protein (roughly 1.6 to 2.2 grams per kg of body weight per day, distributed across the day), consistent sleep, a well-designed training program that manages intensity and volume, and (for most trained adults) creatine monohydrate at 3 to 5 grams per day. If you'd like the deeper reads on those, see the protein distribution research and creatine loading vs maintenance. Rhodiola sits several rungs below those.

Where rhodiola honestly earns a place is in a narrow band of use cases. The person whose weak point is how the workout feels rather than what the workout produces. The person who reliably talks themselves out of hard sessions because effort feels intolerable. The endurance athlete who wants a modest lift in perceived exertion for long steady-state efforts. The trainee heading into a stressful life period who wants to keep their training log intact through it.

Rhodiola also sits differently in a stack than ashwagandha, the other well-studied adaptogen in exercise research. Ashwagandha's evidence base is stronger on strength, muscle mass, and testosterone-related outcomes. Rhodiola's is stronger on perceived exertion and endurance. If you're picking one, pick to the outcome you actually want. If you want both angles covered, they are commonly stacked without documented negative interaction, though the combined-supplementation trials are limited.

How Rhodiola Actually Works Inside the Body

The mechanistic story is still being pieced together, and no honest review would claim otherwise. The two active compound classes that most trials standardize to are the rosavins (rosavin, rosarin, rosin) and the phenylpropanoid salidroside. The SHR-5 extract that De Bock used (and that many follow-up trials adopted) is standardized to 3 percent rosavins and 1 percent salidroside, giving a rough 3-to-1 ratio.

The proposed mechanisms fall into two buckets. On the central side, rhodiola appears to modulate neurotransmitter systems (serotonin, dopamine, norepinephrine) and to reduce activation of the hypothalamic-pituitary-adrenal (HPA) stress axis. That is the pathway that would explain the reduced RPE and improved mood-state findings in the Duncan and Clarke (2014) and De Bock (2004) trials. On the peripheral side, rhodiola compounds appear to influence mitochondrial function, ATP resynthesis, and oxidative-stress buffering in some preclinical models. That would speak to the anaerobic-power finding in Ballmann (2019) and the endurance effects in the 2025 pooled analysis.

The honest caveat is that the peripheral-mechanism story is more speculative than the central one. Preclinical models don't always translate cleanly, and the pooled biomarker data in the 2025 meta-analysis were heterogeneous. The RPE-and-mood pathway has the cleanest chain of evidence from trial to plausible mechanism.

Older research on rhodiola for fatigue helps triangulate. Ishaque, Shamseer, Bukutu, and Vohra (2012) in BMC Complementary and Alternative Medicine systematically reviewed 10 RCTs and 1 controlled clinical trial (11 studies total) on rhodiola for physical and mental fatigue. The mental-fatigue signal was the more favorable one, with 3 of 5 RCTs on mental fatigue showing significant improvements. Physical performance results were more mixed, with only 2 of 6 physical-fatigue trials in healthy participants reporting efficacy. That fingerprint (central signal stronger, peripheral signal weaker but present) matches what the exercise-specific literature has since produced.

Common Misconceptions

Misconception: "Rhodiola is basically a natural caffeine."

No. Rhodiola and caffeine both reduce perceived exertion, but through different pathways. Caffeine is an adenosine-receptor antagonist that stimulates the central nervous system, and its ergogenic effect on endurance is well-established at 2 to 4 percent improvement in most meta-analyses. Rhodiola works more like a stress-buffer, dampening the HPA-axis response and shifting mood state, without the heart-rate acceleration or jittery side-effect profile of a stimulant. Duncan and Clarke (2014) explicitly noted that heart rate did not differ between rhodiola and placebo, which is not what a stimulant does. If you like the "less-jittery ergogenic" pitch, rhodiola fits it. Just don't expect caffeine-magnitude effects.

Misconception: "You have to load rhodiola for weeks to see benefits."

The evidence points the other direction. De Bock (2004) directly compared acute versus 4-week chronic supplementation in the same 24 subjects and found the acute dose worked while chronic did not add. Duncan (2014) and Ballmann (2019) both saw effects after short protocols (single acute dose and 3-day loading, respectively). This makes rhodiola's use pattern more like caffeine (situational) than like creatine or beta-alanine (background loading). Take it when you're doing hard work. Don't take it every day.

Misconception: "All rhodiola supplements are the same."

They are not. The exercise-trial extracts have almost all been standardized to 3 percent rosavins and 1 percent salidroside, either as SHR-5 or an equivalent. Many commercial rhodiola supplements are not standardized, are underdosed, or use root powder (rather than an extract) that provides a fraction of the active compounds per capsule. If a product doesn't list the standardization percentages on the label, treat it as unstudied. This is a general problem with the herbal supplement market, not a rhodiola-specific one, but it's especially pointed with rhodiola because the effective compounds are well-characterized.

What the Research Suggests Going Forward

The rhodiola-and-exercise literature has moved from "single provocative acute-dosing trial" (De Bock 2004) to "small but coherent body of RCTs" (Sanz-Barrio 2023) to "pooled meta-analysis with modest positive effects on endurance outcomes" (2025). That is the shape of a supplement whose effect is real, small, and worth understanding, but not one that should sit at the top of anyone's stack.

Where the field still needs work: larger and better-powered trials in male and female athletes across a wider age band, direct head-to-head comparisons with caffeine, dose-response studies that clarify the acute pre-exercise sweet spot, and clean tests of rhodiola stacked with other ergogenic aids. The 2025 meta-analysis flagged high heterogeneity as the main limitation of the pooled synthesis, and closing that will require the next generation of trials to converge on a common extract and dosing template.

For a healthy adult who wants to try it and see whether it changes how their hard sessions feel, the defensible starting protocol is 200 to 300 mg of standardized extract (3% rosavins, 1% salidroside) taken 60 minutes before the target session, cycled by need rather than taken daily. Track how the workout felt on a 1 to 10 scale over 4 to 6 sessions. If there's no perceived difference by session 6, the substance is unlikely to be doing anything for you.

References

1. De Bock K, Eijnde BO, Ramaekers M, Hespel P. "Acute Rhodiola rosea intake can improve endurance exercise performance." International Journal of Sport Nutrition and Exercise Metabolism 14.3 (2004): 298-307. doi:10.1123/ijsnem.14.3.298.
2. Duncan MJ, Clarke ND. "The Effect of Acute Rhodiola rosea Ingestion on Exercise Heart Rate, Substrate Utilisation, Mood State, and Perceptions of Exertion, Arousal, and Pleasure/Displeasure in Active Men." Journal of Sports Medicine 2014 (2014): 563043. doi:10.1155/2014/563043.
3. Ballmann CG, Maze SB, Wells AC, Marshall MM, Rogers RR. "Effects of short-term Rhodiola rosea supplementation on anaerobic exercise performance." Journal of Sports Sciences 37.9 (2019): 998-1003. doi:10.1080/02640414.2018.1538028.
4. Sanz-Barrio PM, Noreen EE, Schwarz NA, Lozano-Ramos M, Rodríguez-Rosell D. "Rhodiola rosea supplementation on sports performance: A systematic review of randomized controlled trials." Phytotherapy Research 37.10 (2023): 4414-4428. doi:10.1002/ptr.7950.
5. Ishaque S, Shamseer L, Bukutu C, Vohra S. "Rhodiola rosea for physical and mental fatigue: a systematic review." BMC Complementary and Alternative Medicine 12 (2012): 70. doi:10.1186/1472-6882-12-70.

Frequently Asked Questions

Does Rhodiola rosea actually improve exercise performance?

The evidence supports a small, consistent effect on perceived exertion and endurance time-to-exhaustion, with weaker and mixed effects on maximal power. De Bock et al. (2004) in the International Journal of Sport Nutrition and Exercise Metabolism found a single acute 200 mg dose significantly extended time-to-exhaustion during incremental cycling in 24 recreational athletes. Sanz-Barrio et al. (2023) in Phytotherapy Research pooled 13 randomized controlled trials in 263 participants and concluded rhodiola shows modest benefits on RPE and endurance. It is not a strong ergogenic aid on the order of caffeine or creatine.

How much Rhodiola rosea should you take before a workout?

Across the RCTs, the acute pre-exercise doses that produced measurable effects were 200 mg (De Bock 2004), 3 mg per kg of body weight (Duncan and Clarke 2014, roughly 210 to 270 mg for most adults), and 500 mg on top of a 3-day loading protocol (Ballmann et al. 2019). The extracts used were typically standardized to 3 percent rosavins and 1 percent salidroside. Take 30 to 60 minutes before exercise on an empty stomach.

Is chronic (daily) Rhodiola rosea supplementation better than acute dosing?

The acute-versus-chronic comparison is one of the more interesting findings in the literature. De Bock et al. (2004) directly compared a single acute 200 mg dose against 4 weeks of daily 200 mg supplementation in the same 24 subjects and found the acute dose improved time-to-exhaustion while the 4-week chronic phase produced no significant additional effect. This is the opposite pattern of creatine or beta-alanine. For rhodiola, periodic pre-exercise dosing for hard sessions is likely more useful than daily background supplementation.

Is Rhodiola rosea safe? Are there side effects?

In the exercise trials, side-effect reports have been low. Ishaque et al. (2012) systematically reviewed rhodiola for fatigue across 11 studies (446 total participants) and reported only 5 adverse events across 3 studies, all mild in nature (mostly headache and insomnia), comparable to placebo. Rhodiola may interact with antidepressants, blood-thinners, and diabetes medications, and it has stimulant-like properties that can worsen sleep if taken late in the day. Anyone on prescription medication, pregnant, or breastfeeding should clear it with a doctor first.

How does Rhodiola rosea compare to caffeine for exercise?

Caffeine has a much stronger and more consistent ergogenic evidence base than rhodiola. Meta-analyses on caffeine typically show 2 to 4 percent improvements in endurance performance and reliable reductions in RPE. Rhodiola's effects on similar outcomes are smaller and less consistent. Rhodiola's distinctive claim is on the mental side: several trials show reduced perceived exertion, better mood state, and improved cognitive performance under fatigue. If you're choosing between them for raw performance, caffeine wins on the evidence.

Does FitCraft account for supplement use in its programs?

FitCraft builds you a personalized program around your goals, schedule, and fitness level. The training does the work, not the supplements. If you'd like a plan built around what you can actually stick with (rather than one built around what you have to swallow to get through it), take the free FitCraft assessment.